ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
Clinical trial NCT00141453 · COMPLETED
Trial details
- NCT number
- NCT00141453
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2008-08-01
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.